SecBot SecBot
3 ·Filed Nov 10, 2026

OCUL

OCULAR THERAPEUTIX, INC
NEUTRAL
Impact 2/10
Horizonimmediate Processed6d 8h ago SEC0001104659-26-125169
Form 3: initial insider ownership statement
Actionable Insight • Neutral

This is a routine insider onboarding filing with no trading or ownership implications. No further action warranted.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1
Entry
$6.66
T+0 close · Nov 10, 2026 · via day close
Latest settled
−5.71%
T+1 · $6.28
Vs SPY
−5.35%
α at T+1
Next horizon
T+5
tomorrow
  1. T+0 · Nov 11 $6.66entry
  2. T+1 · 5d ago −5.71%α −5.35% · $6.28
  3. T+3 · todayOpen
  4. T+5 · tomorrow Pending
  5. T+20 · in 23d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Riad Sherif filed an initial statement of beneficial ownership (Form 3) with Ocular Therapeutix, reporting no securities owned. The filing is a routine administrative requirement for a new insider and includes a power of attorney authorizing others to file SEC reports on his behalf.

Key Facts

  • Riad Sherif filed a Form 3 initial statement of beneficial ownership on November 10, 2026, with a period of report of November 6, 2026.
  • The filing reports 0 shares, 0 derivative securities, and 0 other securities owned.
  • A power of attorney (Exhibit 24) was included, appointing Donald Notman, Todd Anderman, Jason Robins, and Kathleen Theriault as attorneys-in-fact for SEC filing purposes.
  • The filing is administrative and contains no financial data, transactions, or material corporate events.

Financial Impact

No financial impact; the filing reports zero beneficial ownership.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
95% bullish (19 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
3 Filing (Primary)0001104659-26-125169
Document: 0001104659-26-125169-index-headers.html0001104659-26-125169
Document: 0001104659-26-125169-index.html0001104659-26-125169
Document: 0001104659-26-125169.txt0001104659-26-125169

Track record

20 reports on OCUL

Performance horizon

4 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +24.88% at T+20 after the Aug 3, 2026 report. 5 of 5 went positive at some point.

Filters
  1. Nov 10, 20266d ago 3 Neutral 2/10 Viewing Entry $6.66 Now $6.01 −9.76% settles Nov 18
  2. Nov 9, 20267d ago 8-K Neutral 2/10 Entry $6.85 to $6.01 Now $6.01 −12.26% ▼ −12.26% −10.57% vs SPY
  3. Nov 9, 20267d ago Press Release Bearish 5/10 Entry $6.85 to $6.01 Now $6.01 +12.26% ▲ +12.26% +10.57% vs SPY
  4. Nov 5, 202611d ago 144 Neutral 3/10 Entry $6.60 to $6.21 Now $6.01 −8.87% ▼ −5.84% −8.43% vs SPY
  5. Oct 16, 20264w ago 8-K Neutral 2/10 Entry $6.29 to $6.47 Now $6.01 −4.45% ▲ +2.86% +3.01% vs SPY
  6. Oct 8, 20265w ago 144 Neutral 2/10 Entry $7.54 to $6.87 Now $6.01 −20.29% ▼ −8.89% −6.92% vs SPY
  7. Sep 2, 202610w ago Insider Cluster Neutral 4/10 Entry $10.64 to $10.49 Now $6.01 −43.52% ▼ −1.41% −0.26% vs SPY
  8. Aug 26, 202611w ago Insider Cluster Neutral 3/10 Entry $10.82 to $10.64 Now $6.01 −44.45% ▼ −1.66% −1.93% vs SPY
  9. Aug 3, 202615w ago 8-K Bullish 7/10 Entry $8.40 to $9.24 Now $6.01 −28.45% ▲ +10.00% +7.97% vs SPY
  10. Jun 17, 202621w ago Press Release Bullish 6/10 Entry $9.64 to $9.85 Now $6.01 −37.66% ▲ +2.18% +3.22% vs SPY
Showing 10 of 20

US Market Status

Market Closed · Opens in 8h 52m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 10, 2026